· A number of academicians participating in the research of global original products
· A new generation of brain injury protection/therapeutic first-line drugs
· The world's first ethanolcholine-enhancing injection for organic brain lesions

Specification Iml: 0.2mg
Drug category: Western medicine

Indications: It is suitable for benign memory disorders to improve the patients' ability of pointing memory, associative learning, image recall, meaningless figure recognition and portrait recall. It can also improve memory impairment caused by dementia patients and organic brain lesions. In addition, this product is also used for the treatment of myasthenia gravis.

Pharmacology and Toxicology: Huperzine A is a cholinesterase inhibitor, has a selective inhibitory effect on acetylcholinesterase (ACHE), and is easy to pass through the blood-brain barrier. It has the effect of promoting memory reproduction, enhancing memory retention and strengthening muscle contraction strength.